Immunic AG | Finanzwire

BRIEF

published on 03/10/2026 at 11:35, 7 days 2 hours ago

Immunic Secures European Patent for Vidofludimus Calcium Dosing

Intellectual Property Multiple Sclerosis Immunic Vidofludimus Calcium European Patent
PRESS RELEASE

published on 03/10/2026 at 11:30, 7 days 2 hours ago

Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
Immunic AG announces grant of key European patent protecting relevant dosing regimens for vidofludimus calcium, strengthening global intellectual property strategy

Intellectual Property Vidofludimus Calcium Immunic AG European Patent Dosing Regimens
BRIEF

published on 03/03/2026 at 12:35, 14 days 1 hour ago

Immunic to Attend Key Investor Conferences in March

Biotechnology Investor Conferences Immunic Gastrointestinal Disorders Neurologic Diseases
PRESS RELEASE

published on 03/03/2026 at 12:30, 14 days 1 hour ago

Immunic to Participate in Investor Conferences in March
Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in March, including Leerink Partners Global Healthcare Conference and Stifel 2026 Virtual CNS Forum. Leading late-stage biotechnology company developing novel oral therapies

Biotechnology Investor Conferences Clinical Trials Immunic Inc. Oral Therapies
BRIEF

published on 02/26/2026 at 12:35, 19 days 1 hour ago

Immunic, Inc. Reveals 2025 Financial Outcomes and Strategic Plans

Multiple Sclerosis Vidofludimus Calcium Phase 3 Trials Immunic Financials Private Investment
PRESS RELEASE

published on 02/26/2026 at 12:30, 19 days 1 hour ago

Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports year-end 2025 financial results, announces completion of private placement, and plans for MS programs advancement and commercial transition

Private Placement Immunic Inc. Multiple Sclerosis Year-end Results Commercial Transition
BRIEF

published on 02/17/2026 at 22:10, 27 days 15 hours ago

Immunic Secures Hefty Funding Through Oversubscribed Private Placement

Private Placement Biotechnology Multiple Sclerosis Trials Investor Participation Immunic Financing
PRESS RELEASE

published on 02/17/2026 at 22:05, 27 days 15 hours ago

Immunic Announces Closing of Oversubscribed Private Placement Financing
Immunic closes oversubscribed private placement financing of USD 200 million with potential for additional USD 200 million, aiming to fund phase 3 ENSURE trials and transition to commercialization

Private Placement Biotechnology Financing Immunic ENSURE Trials
BRIEF

published on 02/13/2026 at 12:35, 1 month 4 days ago

Immunic Secures USD 400 Million to Advance Commercial Ambitions

Private Placement Biotechnology Leadership Changes Multiple Sclerosis Immunic AG
PRESS RELEASE

published on 02/13/2026 at 12:30, 1 month 4 days ago

Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
Immunic announces oversubscribed private placement of up to USD 400 million to accelerate transformation into commercial-stage company. New leadership appointments to propel growth

Private Placement Growth Leadership Immunic Commercial-stage

Published on 03/17/2026 at 13:30, 19 minutes ago

Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 19 minutes ago

Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 49 minutes ago

Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland
Published on 03/17/2026 at 13:00, 49 minutes ago

High-Resolution Airborne Survey Completed at Music Valley HREE Project
Published on 03/17/2026 at 12:30, 1 hour 19 minutes ago

Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho

View all ACCESSWIRE

Published on 03/17/2026 at 13:25, 23 minutes ago

Phemex Astral Trading League Launches $450,000 Pisces Season
Published on 03/17/2026 at 13:05, 43 minutes ago

Golden Helix Partners with the Austrian Human Genetics Labs to Drive Advancements in Genomic Medicine
Published on 03/17/2026 at 12:08, 1 hour 41 minutes ago

Notice of the 2026 annual general meeting of Ørsted A/S
Published on 03/17/2026 at 12:02, 1 hour 46 minutes ago

Enapter AG expands global Core Partner network with U.S.-based Total Hydrogen Solutions
Published on 03/17/2026 at 12:00, 1 hour 49 minutes ago

Nebius Group announces proposed private offering of $3.75 billion of convertible senior notes

View all EQS

Published on 03/17/2026 at 07:00, 6 hours 49 minutes ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 19 hours 49 minutes ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 19 hours 51 minutes ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 19 hours 52 minutes ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 20 hours 4 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News